abstract |
A procedure for treating atherosclerosis is described, in which the patient is administered nicotinic acid or another nicotinic acid receptor agonist in combination with another DP receptor antagonist. The DP receptor antagonist is administered to reduce, prevent or eliminate blushing, which might otherwise occur. |